Type 1 diabetes is a chronic autoimmune condition in which the body’s immune system destroys the cells in the pancreas that produce insulin. Without insulin, glucose builds up in the bloodstream instead of entering cells for energy. An estimated 9.5 million people worldwide are living with Type 1 diabetes as of 2025, and roughly 513,000 new cases are diagnosed each year.
Unlike Type 2 diabetes, which develops gradually and is linked to lifestyle factors, Type 1 is not preventable and is not caused by diet or exercise habits. It can appear at any age, though it’s most commonly diagnosed in children, teens, and young adults. About 1.8 million of the people currently living with Type 1 are under 20.
What Happens Inside the Body
In a healthy pancreas, clusters of cells called islets contain beta cells that produce insulin. Insulin acts like a key, allowing glucose from food to move out of the bloodstream and into your muscles, liver, and fat cells where it’s used for energy. In Type 1 diabetes, certain immune cells (specifically T cells) mistakenly identify beta cells as threats and attack them.
The process unfolds over months or years before symptoms appear. First, stressed beta cells begin displaying abnormal surface signals that attract immune cells. Those immune cells release inflammatory chemicals that recruit even more immune cells into the pancreas. Helper T cells coordinate the attack while killer T cells directly destroy beta cells. By the time symptoms show up, the immune system has already wiped out a significant portion of insulin-producing capacity.
What triggers this immune response isn’t fully understood, but it involves a combination of genetic susceptibility and environmental factors. Certain gene variants related to immune function increase risk, though most people with those genes never develop Type 1. Something in the environment, possibly a viral infection or other stressor, appears to tip the balance.
Symptoms and How Quickly They Appear
Type 1 diabetes symptoms typically develop fast, over a few days to a few weeks. The hallmark signs include:
- Frequent urination: excess glucose spills into urine, pulling water along with it
- Extreme thirst: a direct result of fluid loss from frequent urination
- Unexplained weight loss: without insulin, the body breaks down fat and muscle for energy
- Constant hunger: cells are starved for glucose even though blood sugar is high
- Fatigue: without glucose reaching cells, energy drops significantly
- Blurred vision: high blood sugar pulls fluid from the lenses of the eyes
In children, bedwetting in a previously dry child is sometimes an early clue. The rapid onset is one way Type 1 differs from Type 2, where symptoms can be subtle for years.
How Type 1 Is Diagnosed
Diabetes is confirmed through blood tests. The American Diabetes Association uses several thresholds: a fasting blood glucose of 126 mg/dL or higher, a random blood glucose of 200 mg/dL or higher with classic symptoms, or an A1C (a measure of average blood sugar over two to three months) of 6.5% or higher. Usually the test needs to be repeated on a second day unless symptoms and results are clearly elevated.
Those tests confirm diabetes, but they don’t distinguish Type 1 from Type 2. That distinction matters because the treatment is fundamentally different. To confirm the autoimmune nature of Type 1, doctors test for specific autoantibodies in the blood. The four primary ones target insulin, an enzyme called GAD, a protein called IA-2, and a zinc transporter called ZnT8. The presence of one or more of these antibodies points to an immune-mediated process. The more antibodies detected, the stronger the diagnostic and predictive signal. Some of these antibodies appear in the blood years before symptoms develop, which is why screening at-risk relatives (such as siblings of someone with Type 1) can catch the disease in its earliest stages.
Stages of the Disease
Type 1 diabetes is now understood to progress through three stages. In Stage 1, autoantibodies are present in the blood but blood sugar is still normal. There are no symptoms. In Stage 2, blood sugar starts to become abnormal, but the person still doesn’t feel sick. Stage 3 is the clinical diagnosis, when enough beta cells have been destroyed that symptoms appear and insulin therapy becomes necessary.
This staging system matters because it opens a window for early intervention. In 2022, a drug that modifies the immune response became the first treatment approved to delay progression from Stage 2 to Stage 3. In clinical trials, it pushed back the onset of full-blown diabetes by a median of about two years, with the strongest effect in the first year. That delay can be meaningful, particularly for young children whose families gain extra time before managing daily insulin therapy.
Living With Type 1: Insulin and Monitoring
Everyone with Type 1 diabetes needs insulin from the moment of diagnosis and for the rest of their life. The pancreas simply cannot make it anymore. The goal is to mimic what a healthy pancreas does naturally: provide a steady baseline of insulin throughout the day and release extra bursts when you eat.
Most people achieve this with either multiple daily injections or an insulin pump. With injections, you typically take a long-acting insulin once or twice a day for baseline coverage and a rapid-acting insulin before meals. An insulin pump, worn on the body, delivers rapid-acting insulin continuously through a tiny catheter under the skin, with additional doses programmed at mealtimes.
Modern pump systems can pair with a continuous glucose monitor (CGM), a small sensor worn on the skin that reads blood sugar levels every few minutes. The most advanced systems, sometimes called closed-loop or “artificial pancreas” systems, automatically adjust insulin delivery based on CGM readings, increasing it when blood sugar rises and reducing or suspending it when levels drop. These systems don’t eliminate the need for user input entirely, but they significantly reduce the daily mental burden of managing blood sugar.
Even with good technology, managing Type 1 requires constant attention. Carbohydrate counting, activity levels, stress, illness, and sleep all affect blood sugar. The target is to keep glucose in a relatively narrow range: high enough to avoid dangerous lows (hypoglycemia) and low enough to prevent long-term complications from chronic highs.
Diabetic Ketoacidosis: The Acute Danger
When the body has little or no insulin, it can’t use glucose for fuel and starts breaking down fat at an accelerated rate. This process produces acids called ketones. When ketones build up faster than the body can clear them, the blood becomes dangerously acidic, a condition called diabetic ketoacidosis (DKA). It’s defined by blood glucose typically above 250 mg/dL, blood acidity below a pH of 7.3, and the presence of ketones in the blood or urine.
DKA can develop within hours and is a medical emergency. Symptoms include nausea, vomiting, abdominal pain, fruity-smelling breath, rapid breathing, and confusion. It’s the most common way Type 1 is first discovered in children, and it remains a risk throughout life during illness, pump malfunctions, or missed insulin doses. Knowing the warning signs and checking for ketones when blood sugar runs high are essential skills for anyone living with Type 1.
How Type 1 Differs From Type 2
The two types share a name and the problem of high blood sugar, but they’re fundamentally different diseases. Type 1 is autoimmune: the body destroys its own insulin-producing cells. Type 2 is metabolic: the body still makes insulin but cells become resistant to it, and over time the pancreas can’t keep up with demand.
Type 2 is far more common, accounting for roughly 90% of all diabetes cases. It’s strongly associated with excess weight, physical inactivity, and age, and it can often be managed initially with lifestyle changes and oral medications. Type 1 cannot be managed with diet or pills alone. Insulin is non-negotiable from day one. Type 1 also tends to appear earlier in life, though adult-onset Type 1 is more common than previously thought, and is sometimes misdiagnosed as Type 2 in adults. Autoantibody testing is the clearest way to tell them apart.